Indefinite Delivery Contract SPE2DX15D6907

The federal contract IDV award SPE2DX15D6907 is an Indefinite Delivery Contract (IDC) between the Defense Logistics Agency (DLA) and the prime contractor DMS Pharmaceutical Group Inc., a woman-owned small business based in Park Ridge, Illinois. The $4,999,999.00 single-award IDC, awarded on March 23, 2017, covers the supply of a wide range of pharmaceutical products, including branded and generic prescription drugs, over-the-counter medications, biologics, and medical consumables to support the recurring medical supply needs of military health facilities worldwide under the DLA's Medical Supply Chain program.

Through this IDC, DMS Pharmaceutical Group provides a comprehensive array of pharmaceutical items, from common medications like antibiotics and pain relievers to specialized drugs, biologics, and medical supplies such as flumazenil injections, prednisone tablets, epinephrine auto-injectors, and oncology drugs. The contract, which runs through December 25, 2024, allows the DLA to issue firm fixed-price delivery orders to DMS Pharmaceutical Group to fulfill the diverse medical requirements of the Department of Defense (DoD) and its healthcare facilities globally. This IDC complements the company's existing prime vendor contracts for direct distribution of prescription drugs and pharmacy services to DoD sites, solidifying its position as a crucial supplier in the federal pharmaceutical supply chain.